<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00669227</url>
  </required_header>
  <id_info>
    <org_study_id>SCAMI 01-04</org_study_id>
    <nct_id>NCT00669227</nct_id>
  </id_info>
  <brief_title>Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI)</brief_title>
  <acronym>SCAMI</acronym>
  <official_title>Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction - A Randomized, Double-blind, Placebo Controlled Trial (SCAMI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Ulm</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Ulm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autologous stem cells may improve myocardial regeneration after intracoronary administration
      in patients with acute myocardial infarction. The primary hypothesis of this prospective,
      placebo-controlled, double-blind trial is that the increase of ejection fraction determined
      by magnetic resonance imaging between baseline and 6 months follow-up is superior in active
      treated patients compared to patients receiving placebo. The study includes an integrated
      pilot phase of 40 patients for evaluation of left ventricular ejection fraction determined by
      cardiac magnetic resonance imaging. Based on the data of this analysis the final sample size
      will be calculated. The primary endpoint is the improvement in left ventricular ejection
      fraction with an assumed 2.5% higher improvement in the cell treated population compared to
      the placebo treated group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is a 2:1 randomization for bone marrow cell therapy versus placebo therapy. Patients
      will be stratified according to age, localization of myocardial infarction and left
      ventricular function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>difference in left ventricular ejection fraction measured by magnetic resonance imaging at baseline and 6 months follow-up</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>left ventricular ejection fraction measured by magnetic resonance imaging</measure>
    <time_frame>1, 3, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>left ventricular enddiastolic volume measured by magnetic resonance imaging</measure>
    <time_frame>1, 3, 6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>left ventricular endsystolic volume measured by magnetic resonance imaging</measure>
    <time_frame>1, 3, 6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major adverse cardiac events</measure>
    <time_frame>1, 3, 6, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>autologous stem cells, Ficoll preparation, intracoronary administration at the same day of bone marrow cell aspiration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo is visually indistinguishable from verum due to integration of autologous erythrocytes, intracoronary administration the same day of bone marrow aspiration</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>autologous stem cells</intervention_name>
    <description>intracoronary administration at the same day of cell aspiration using the stop flow technique</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo suspension</intervention_name>
    <description>intracoronary administration at the same day as cell aspiration</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute myocardial infarction with time to revascularization &gt;6 hours from symptom start

          -  clear target vessel

          -  large myocardial infarction defined as: proximal vessel occlusion, CK &gt; 1000 U/L,
             myocardial scar in magnetic resonance imaging &gt; 10% of left ventricular muscle mass

          -  potential prior thrombolysis

          -  written informed consent

        Exclusion Criteria:

          -  acute myocardial infarction with revascularization within 6 hours after symptom start

          -  prior myocardial infarction

          -  no clear target vessel

          -  contraindication for magnetic resonance imaging (e.g. pacemaker, ICD)

          -  severely depressed left ventricular ejection fraction (less than 20% in magnetic
             resonance imaging)

          -  prior hematologic disease

          -  prior chemo therapy

          -  prior stem cell transplantation

          -  prior treatment with G-CSF

          -  known alteration of the bone marrow by alcohol or drugs, e.g. agranulocytosis

          -  local infection of puncture sites
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jochen Wöhrle, MD; FESC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ulm</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Wöhrle J, Merkle N, Mailänder V, Nusser T, Schauwecker P, von Scheidt F, Schwarz K, Bommer M, Wiesneth M, Schrezenmeier H, Hombach V. Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol. 2010 Mar 15;105(6):804-12. doi: 10.1016/j.amjcard.2009.10.060.</citation>
    <PMID>20211323</PMID>
  </reference>
  <reference>
    <citation>Wöhrle J, von Scheidt F, Schauwecker P, Wiesneth M, Markovic S, Schrezenmeier H, Hombach V, Rottbauer W, Bernhardt P. Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction (SCAMI) trial. Clin Res Cardiol. 2013 Oct;102(10):765-70. doi: 10.1007/s00392-013-0595-9. Epub 2013 Jul 30.</citation>
    <PMID>23896972</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2008</study_first_submitted>
  <study_first_submitted_qc>April 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2008</study_first_posted>
  <last_update_submitted>June 7, 2014</last_update_submitted>
  <last_update_submitted_qc>June 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Ulm</investigator_affiliation>
    <investigator_full_name>Jochen Wohrle</investigator_full_name>
    <investigator_title>Prof. Dr. Jochen Wöhrle</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

